Axillary lymph node metastases: A statistical analysis of various parameters in MRI with USPIO

Journal of Magnetic Resonance Imaging

Volumn 16, Issue 1, 2002, Pages 60-68

  Stets, Constanze ^a   Brandt, Silvio ^a   Wallis, Fintan ^b   Buchmann, Jörg ^a   Gilbert, F J ^b   Heywang Köbrunner, Sylvia H ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Axilla; Breast cancer; Contrast agent; Lymph nodes; MRI

Indexed keywords

ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ARTICLE; AXILLARY LYMPH NODE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE METASTASIS; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAMETER; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; STATISTICAL ANALYSIS;

AXILLA; BREAST NEOPLASMS; CONTRAST MEDIA; FEMALE; HUMANS; IRON; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; OXIDES; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY;

EID: 0036288846     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.10134     Document Type: Article

References (21)

1. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases
2. Relation of number of positive axillary lymph nodes to the prognosis of patients with primary breast cancer. An NSABP update
3. Prognostic significance of axillary nodal status in primary breast cancer in relation to the number of resected nodes
4. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?
5. Sentinel lymphadenectomy: A safe answer to less axillary surgery?
6. Lymphatic mapping in breast cancer
7. Axillary clearance in operable breast cancer: Still a necessity?
8. Update of the Swedish two-county program of mammographic screening for breast cancer
9. Initial clinical experience with dextran-coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer
10. Phase I clinical evaluation of a new iron oxide MR contrast agent
11. Ultra small super paramagnetic iron oxide: An intravenous contrast agent for assessing lymph nodes with MR imaging
12. Ultra small super paramagnetic iron oxide: Characterization of a new class of contrast agent for MR imaging
13. Iron oxide-enhanced MR lymphography: Initial experience
14. MR lymphography with superparamagnetic iron nanoparticles in rats: Pathologic basis for contrast enhancement
15. AMI-227-enhanced MR lymphography: Usefulness for differentiating reactive from tumour-bearing lymph nodes
16. Characterization of reactive versus tumour-bearing lymph nodes with interstitial magnetic resonance in animal model
17. Iron oxide-enhanced MR lymphography: The evaluation of cervical lymph node metastases in the head and neck cancer
18. Lymph node metastases: Safety and effectiveness of MR imaging with ultra small super paramagnetic iron oxide particles-initial clinical experience
19. MR lymphography using ultra small super paramagnetic iron oxide in patients with primary abdominal and pelvic malignancies: Radiographic-pathologic correlation
20. Multicenter clinical trial of ultra small super paramagnetic iron oxide in the evaluation of mediastinal lymph nodes in patients with primary lung carcinoma
21. The steady state signals in short-repetition-time sequences